Dentons advises Immunic on second closing of series A financing round

The Munich-based biotech company has raised an overall amount of €21.7 million so far in its series A financing round and will accelerate projects for the therapy of autoimmune diseases with the additional €4 million from the second closing.

Test tubes
Test tubes
 
Redirection

You are switching to another language. Please click Confirm below to continue.

 
Important Notice